Regulatory Approval

Nasdaq-listed Zeta Network Group is exploring real-world asset tokenization, signaling a pivotal move beyond Bitcoin for institutional treasury management.

In a landmark deal for Canadian fintech, a federally regulated bank will custody QCAD's reserves, paving the way for institutional stablecoin adoption.

Aethlon Medical's upcoming Q3 report puts its finances under a microscope as investors weigh a tight cash runway against progress on its Hemopurifier device.

A new biotech partnership is accelerating development of a once-daily tablet for hypoparathyroidism, a rare disease currently requiring injections.

The Bozeman tech firm saw record growth as the energy sector embraces its advanced LiDAR for methane detection and navigating complex global regulations.

A new six-month injection for Central Precocious Puberty shows strong safety and efficacy, promising to ease the treatment burden for children and families.

Vertical Aerospace and Marubeni target 2026 demo flights in Osaka, accelerating Japan's race to launch commercial electric air taxi services.

As the FDA embraces advanced Bayesian statistics, MedTech firm BioStem sees validation for its wound care research, promising faster innovation for patients.

Commonwealth LNG's 20-year deal with Mercuria for 1 Mtpa of LNG nears project financing, despite facing significant environmental and regulatory hurdles.

The tire giant's latest deal for a sealing specialist signals an aggressive push into high-value materials, moving far beyond its rubber-and-road legacy.

The EpiFaith® Smart Syringe secures landmark deals with the UK's NHS and Paris's AP-HP, signaling a new era for patient safety and market access.

After a four-year campaign, the World Health Organization is poised to recognize a silent liver epidemic, setting the stage for a new global NCD strategy.

Canada's first compliant stablecoin, QCAD, partners with VersaBank, leveraging bank-grade security to bridge the gap between crypto and traditional finance.

A new partnership between tech firm OnBoard and Stanford experts aims to redefine corporate governance with AI, promising greater insight and accountability.

UK insurers face a tight deadline for tough new PRA collateral rules. A new solution from Transcend aims to ease the burden and enhance risk oversight.

Asurity and MISMO are spearheading a data revolution to standardize mortgage compliance, promising huge efficiency gains and a new era of regulatory clarity.

A major multi-vendor study confirms AI's power for precision HER2 scoring, promising to improve diagnostics and accelerate personalized cancer therapies.

Regulators deem PRRS-resistant pigs safe, promising a future with less animal disease and antibiotic use, but sparking debate on consumer transparency.

Quanterix has submitted a multi-biomarker blood test to the FDA, a move that could revolutionize early Alzheimer's diagnosis and patient care.

A bipartisan bill in Congress aims to give veterans access to emerging mental health treatments, including the novel, non-hallucinogenic compound MEAI.